Sign in
4

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001689375-24-000039

Chief Financial Officer sold 1,758 shares at $14.95 ($26,282)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
WENTWORTH KORY JAMES Chief Financial Officer 2024-07-08 Sale 10b5-1 −1,758 $14.95 $26,282 81,412 D: show line 1 in the form
Open-market sales · 1,758 sh · avg $14.95 · $26,282
Loading xslF345X05/wk-form4_1720643672.xml…